Transitional care for older patients after emergency department visits

Geriatric Transitional Care for Older Patients Discharged From the Emergency Department: Impact on Early Readmissions

Not applicable Interventional Assistance Publique - Hôpitaux de Paris · NCT05814328

This study tests if special care from Mobile Geriatrics Teams can help older adults who leave the emergency room avoid going back to the hospital too soon.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment1322 (estimated)
Ages75 Years and up
SexAll
SponsorAssistance Publique - Hôpitaux de Paris Academic / other
Locations1 site (Paris)
Trial IDNCT05814328 on ClinicalTrials.gov

What this trial studies

This study evaluates the effectiveness of transitional care initiated by Mobile Geriatrics Teams (MGTs) for elderly patients discharged from the emergency department (ED). It focuses on adults aged 75 and older who are at risk for early readmissions, assessing their medical journey and autonomy over a six-month period. The study is multicenter and non-randomized, comparing outcomes between those receiving transitional care and a control group receiving standard recommendations. Participants must consent to the study and meet specific inclusion criteria, while those with severe cognitive or psychiatric disorders may be included if a relative is present.

Who should consider this trial

Good fit: Ideal candidates are adults aged 75 or older, living at home, and identified as at risk for readmission based on a Triage Risk Screening Tool score.

Not a fit: Patients living in nursing homes or those with severe cognitive impairments without a relative present will not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could significantly reduce early readmission rates for elderly patients, improving their overall health outcomes.

How similar studies have performed: Previous studies have indicated that transitional care models can lead to better outcomes for elderly patients, suggesting a promising approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient admitted to the emergency departement over 75 years old and living at home (including independent residence)
* Patient admitted to the Emergency Reception Service (ERS) for less than 48 hours for whom a return home has been decided
* Identified at risk of readmissions to the emergency departement with a Triage Risk Screening Tool (TRST) score \> 2.
* Consent to the study possible at the time of his visit to the emergency room by the patient or a caregiver present at the time of inclusion.
* Patient affiliated with a social security (beneficiary or partner)

Exclusion Criteria:

* Person living in an nursing home
* Severe cognitive impairment according to DSM V criteria and absence of a close relative at the time of inclusion
* Unstabilized psychiatric pathology and absence of relatives at the time of inclusion
* Language barrier and absence of relatives at the time of inclusion
* Person under guardianship, under legal safeguard measure, deprived of liberty by judicial or administrative decision, persons subject to psychiatric care without their consent, persons admitted to a health or social establishment for purposes other than those of the research
* Patient under state medical assistance
* Patient already included in the research

Where this trial is running

Paris

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Hospital Readmissions of Elderly PatientsEmergency, Elderly Patients, Geriatrics, transitional Care
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.